Browsing Tag
Gaurav Mehta
1 post
Why Shilpa’s bet on Alveolus Bio may reshape the future of pulmonary biologics
Shilpa Medicare leads funding round in Alveolus Bio to accelerate Phase 2 COPD trials and first-in-human studies for novel inhaled therapeutics.